Spruce Biosciences News and Activities

View the org chart displaying its 21 main executives

Most searched biographies at Spruce Biosciences

• Javier Szwarcberg, Chief Executive Officer and Director
• Tiba Aynechi, Director
• Camilla Simpson, Independent Director

Popular executive movements at Spruce Biosciences

• Agnieszka Jurecka has joined the company as Vice President, Medical Affairs  (posted on June 22 2026).
• Eric Jordan has joined the company as Vice President, Marketing  (posted on June 16 2026).
• Tina Gullotta has joined the company as Vice President, Finance and Corporate Controller  (posted on June 16 2026).

Click here to view some more movements at Spruce Biosciences

Create your alert
to follow the executive moves at Spruce Biosciences.

Spruce Biosciences has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Spruce Biosciences

• Spruce Biosciences to Participate in June Investor Conferences | Spruce Biosciences
• Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference | Spruce Biosciences
• Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update | Spruce Biosciences
• Spruce Biosciences to Participate in May Investor Conferences | Spruce Biosciences
• Spruce Biosciences to Participate in September Investor Conferences | Spruce Biosciences
• Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual R&D Day | Spruce Biosciences
• Spruce Biosciences to Host Virtual R&D Day on August 25, 2021 | Spruce Biosciences
• News Releases | Spruce Biosciences
• Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates | Spruce Biosciences
• Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors | Spruce Biosciences
• View more press releases Close

Social media about Spruce Biosciences

• Spruce Biosciences on Wikipedia, Google News & Yahoo Finance
• Spruce Biosciences on LinkedIn, X (Twitter) & YouTube